Published in Radiology on November 01, 2006
PET and MR imaging: the odd couple or a match made in heaven? J Nucl Med (2013) 1.05
Cardiovascular magnetic resonance in the diagnosis of acute heart transplant rejection: a review. J Cardiovasc Magn Reson (2009) 1.02
Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon. Cancer (2009) 1.02
Cost modeling of preoperative axillary ultrasound and fine-needle aspiration to guide surgery for invasive breast cancer. Ann Surg Oncol (2010) 0.98
Magnetic resonance imaging of cells in experimental disease models. Prog Nucl Magn Reson Spectrosc (2009) 0.92
The Comparative Study of Ultrasonography, Contrast-Enhanced MRI, and (18)F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast Cancer. J Breast Cancer (2013) 0.90
Accurate prediction of nodal status in preoperative patients with pancreatic ductal adenocarcinoma using next-gen nanoparticle. Transl Oncol (2013) 0.88
Characterization of ex vivo healthy human axillary lymph nodes with high resolution 7 Tesla MRI. Eur Radiol (2010) 0.85
Accuracy of computed tomography perfusion in assessing metastatic involvement of enlarged axillary lymph nodes in patients with breast cancer. Breast Cancer Res (2007) 0.85
Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON). J Magn Reson Imaging (2008) 0.83
Contrast-enhanced MR imaging of lymph nodes in cancer patients. Korean J Radiol (2010) 0.81
Anatomical, Physiological, and Molecular Imaging for Pancreatic Cancer: Current Clinical Use and Future Implications. Biomed Res Int (2015) 0.78
Contribution of kinetic characteristics of axillary lymph nodes to the diagnosis in breast magnetic resonance imaging. Balkan Med J (2012) 0.78
Pre-operative sentinel lymph node localization in breast cancer with superparamagnetic iron oxide MRI: the SentiMAG Multicentre Trial imaging subprotocol. Br J Radiol (2015) 0.78
Is imaging the future of axillary staging in breast cancer? Eur Radiol (2013) 0.77
Diagnostic accuracy of metastatic axillary lymph nodes in breast MRI. Springerplus (2016) 0.75
Individually stabilized, superparamagnetic nanoparticles with controlled shell and size leading to exceptional stealth properties and high relaxivities. ACS Appl Mater Interfaces (2017) 0.75
A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors. Clin Cancer Res (2011) 2.79
Clinical Cerenkov luminescence imaging of (18)F-FDG. J Nucl Med (2013) 2.63
Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer. J Neurooncol (2007) 1.90
Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. J Clin Invest (2011) 1.88
Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg (2004) 1.72
Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? Radiology (2009) 1.67
Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results. Radiology (2007) 1.67
Intensified local treatment and systemic therapy significantly increase survival in patients with brain metastases from advanced breast cancer - a retrospective analysis. Radiother Oncol (2006) 1.63
Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme. J Magn Reson Imaging (2002) 1.59
Prostate postbrachytherapy seed distribution: comparison of high-resolution, contrast-enhanced, T1- and T2-weighted endorectal magnetic resonance imaging versus computed tomography: initial experience. Int J Radiat Oncol Biol Phys (2007) 1.58
Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int J Cancer (2003) 1.50
Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer. Wien Klin Wochenschr (2004) 1.45
Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer. J Clin Oncol (2007) 1.42
Image quality of a wet laser printer versus a paper printer for full-field digital mammograms. AJR Am J Roentgenol (2006) 1.40
Decentral gene expression analysis for ER+/Her2- breast cancer: results of a proficiency testing program for the EndoPredict assay. Virchows Arch (2012) 1.37
CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8. Clin Cancer Res (2012) 1.33
Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group. J Clin Oncol (2012) 1.32
Readout-segmented echo-planar imaging improves the diagnostic performance of diffusion-weighted MR breast examinations at 3.0 T. Radiology (2012) 1.25
US-guided 14-gauge core-needle breast biopsy: results of a validation study in 1352 cases. Radiology (2008) 1.20
Probably benign breast masses at US: is follow-up an acceptable alternative to biopsy? Radiology (2007) 1.18
Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb Haemost (2003) 1.13
Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories. Virchows Arch (2002) 1.12
Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience. Invest Radiol (2005) 1.10
Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted? Radiology (2004) 1.09
Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging. Clin Cancer Res (2008) 1.07
Do we need HER-2/neu testing for all patients with primary breast carcinoma? Cancer (2003) 1.05
Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches. Clin Neuropathol (2012) 1.05
Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: initial phase II multicenter trial. Radiology (2003) 1.05
The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer. Clin Cancer Res (2014) 1.04
MRI assessment of cervical cancer for adaptive radiotherapy. Strahlenther Onkol (2009) 1.04
Preoperative core needle biopsy does not increase local recurrence rate in breast cancer patients. Breast Cancer Res Treat (2006) 1.03
Stereotactic 11-gauge vacuum-assisted breast biopsy: influence of number of specimens on diagnostic accuracy. Radiology (2004) 1.02
MRI-only lesions: application of diffusion-weighted imaging obviates unnecessary MR-guided breast biopsies. Eur Radiol (2014) 1.02
Orthotopic microvascular reanastomosis of whole cryopreserved ovine ovaries resulting in pregnancy and live birth. Fertil Steril (2006) 1.01
Stereotactic 11-gauge vacuum-assisted breast biopsy: a validation study. AJR Am J Roentgenol (2002) 1.01
Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clin Cancer Res (2007) 1.00
Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14. J Clin Oncol (2007) 1.00
Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group. J Clin Oncol (2005) 0.98
Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk. Cochrane Database Syst Rev (2013) 0.98
Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer. Eur Radiol (2010) 0.97
High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin. J Clin Oncol (2003) 0.97
Rate of malignancy in MRI-detected probably benign (BI-RADS 3) lesions. AJR Am J Roentgenol (2014) 0.96
High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: can underestimation be predicted? Eur Radiol (2010) 0.96
Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapy. Breast Cancer Res Treat (2003) 0.93
Virally directed fluorescent imaging improves diagnostic sensitivity in the detection of minimal residual disease after potentially curative cytoreductive surgery. J Gastrointest Surg (2005) 0.93
Image quality, lesion detection, and diagnostic efficacy in digital mammography: full-field digital mammography versus computed radiography-based mammography using digital storage phosphor plates. Eur J Radiol (2007) 0.92
Using a dedicated lung-marker system for localization of pulmonary nodules before thoracoscopic surgery. AJR Am J Roentgenol (2003) 0.92
Computer-assisted quantitative assessment of power Doppler US: effects of microbubble contrast agent in the differentiation of breast tumors. Eur J Radiol (2005) 0.91
Unenhanced multi-detector row CT in patients suspected of having urinary stone disease: effect of section width on diagnosis. Radiology (2005) 0.90
3D versus 2D ultrasound: accuracy of volume measurement in human cadaver kidneys. Invest Radiol (2002) 0.89
Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer. Breast Cancer Res Treat (2003) 0.88
Neoadjuvant chemotherapy increases the rate of breast conservation in lobular-type breast cancer patients. Ann Surg Oncol (2011) 0.88
Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy. Clin Cancer Res (2009) 0.87
Mammography: EUSOBI recommendations for women's information. Insights Imaging (2011) 0.87
Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer. Eur J Cancer (2012) 0.87
[Diagnostic management of nipple discharge]. Wien Klin Wochenschr (2003) 0.86
Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer. BMC Cancer (2009) 0.86
Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancer. Breast Cancer Res Treat (2006) 0.86
Comparison of sitting versus prone position for stereotactic large-core breast biopsy in surgically proven lesions. AJR Am J Roentgenol (2002) 0.85
Unenhanced MDCT in patients with suspected urinary stone disease: do coronal reformations improve diagnostic performance? AJR Am J Roentgenol (2007) 0.85
Bilateral diffusion-weighted MR imaging of breast tumors with submillimeter resolution using readout-segmented echo-planar imaging at 7 T. Radiology (2014) 0.84
MRI-Guided percutaneous biopsy of breast lesions: materials, techniques, success rates, and management in patients with suspected radiologic-pathologic mismatch. Magn Reson Imaging Clin N Am (2006) 0.84
Introduction of an automated user-independent quantitative volumetric magnetic resonance imaging breast density measurement system using the Dixon sequence: comparison with mammographic breast density assessment. Invest Radiol (2015) 0.84
Strategies for the covalent conjugation of a bifunctional chelating agent to albumin: synthesis and characterization of potential MRI contrast agents. J Inorg Biochem (2010) 0.84
Gene expression of PMP22 is an independent prognostic factor for disease-free and overall survival in breast cancer patients. BMC Cancer (2010) 0.84
Her2 and progesterone receptor status are not predictive of response to fulvestrant treatment. Clin Cancer Res (2007) 0.84
Molecular Imaging in Breast Cancer - Potential Future Aspects. Breast Care (Basel) (2011) 0.83
Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer. Cancer Chemother Pharmacol (2008) 0.83
Adjunct ultrasonography for breast cancer screening in women at average risk: a systematic review. Int J Evid Based Healthc (2013) 0.82
CDK10 is not a target for aberrant DNA methylation in breast cancer. Anticancer Res (2009) 0.82
Adjuvant sequencing of tamoxifen and anastrozole is superior to tamoxifen alone in postmenopausal women with low proliferating breast cancer. Clin Cancer Res (2011) 0.82
Diffusion-weighted magnetic resonance imaging of head and neck squamous cell carcinomas. Eur J Radiol (2008) 0.82
Impact of HER-2-targeted therapy on overall survival in patients with HER-2 positive metastatic breast cancer. Breast J (2013) 0.81
Potential of dose reduction after marker placement with full-field digital mammography. Invest Radiol (2005) 0.81
Comparison of 5-megapixel cathode ray tube monitors and 5-megapixel liquid crystal monitors for soft-copy reading in full-field digital mammography. Eur J Radiol (2009) 0.80
Utility (or not) of Gd-DTPA-based dynamic MRI for breast cancer diagnosis and grading. Acad Radiol (2002) 0.80
Portable PET probes are a novel tool for intraoperative localization of tumor deposits. Ann Surg Innov Res (2009) 0.80
Sensitivity of a direct computer-aided detection system in full-field digital mammography for detection of microcalcifications not associated with mass or architectural distortion. Can Assoc Radiol J (2010) 0.80
Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients. Breast Cancer Res Treat (2007) 0.80
Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer. Gynecol Oncol (2004) 0.80
The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer. Breast Cancer Res Treat (2008) 0.79
High-resolution magnetic resonance imaging and conventional magnetic resonance imaging on a standard field-strength magnetic resonance system compared to arthroscopy in patients with suspected meniscal tears. Acad Radiol (2008) 0.78
[Stereotactically and sonographically guided vacuum-assisted breast biopsy: a national consensus for Austria]. Rofo (2002) 0.78
[Breast Imaging Reporting and Data System (BI-RADS)--German version]. Rofo (2002) 0.78
MDCT angiography for detection of pulmonary emboli: comparison between equi-iodine doses of iomeprol 400 mgI/mL and iodixanol 320 mgI/mL. Eur J Radiol (2008) 0.78
TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family. Breast Cancer Res Treat (2015) 0.78
Diagnostic accuracy of (18)F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T. Eur J Nucl Med Mol Imaging (2015) 0.78
Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients. Pharmacoeconomics (2015) 0.78